LYMPH Trial Comparing Microsurgical and Conservative Treatments for Chronic Breast Cancer-Related Lymphedema An International Randomized Multicenter Study
Led by University Hospital, Basel, Switzerland · Updated on 2026-10-22
280
Participants Needed
36
Research Sites
456 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether lymphatic surgery offers better quality of life compared to conservative treatment for patients with chronic breast cancer-related lymphedema. This study aims to provide solid scientific evidence on the superiority of surgical techniques over standard conservative therapy, addressing the physical, psychological, and financial burdens faced by affected patients. It is a pragmatic, randomized, multicenter trial designed to compare these treatments in real-world conditions.
Participants are assigned to one of two groups the surgical group receiving advanced microsurgical procedures such as lymphovenous anastomosis and vascularized lymph node transfer, possibly combined with liposuction, or the conservative therapy group receiving complex physical decongestion therapy CDT. CDT includes manual lymphatic drainage, compression with bandages or garments, physical exercises, and skin care in two phases an intensive phase and a maintenance phase. Both treatments are delivered according to usual care practices with flexibility for the treating clinicians.
Throughout the study, participants complete quality of life questionnaires at baseline and 15 months after randomization, with long-term assessments continuing up to 10 years. Researchers will monitor pain, surgical complications, lymphangitic events, arm volume, frequency of lymphatic drainage, patient burden, and economic factors. Safety and adverse events are assessed for up to two years. The study is sponsored by the University Hospital Basel, Switzerland, and participants are followed for many years to understand the lasting impacts of each treatment approach.
CONDITIONS
Brief Title
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
Research Team
E
Elisabeth Kappos, Prof. Dr.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
A surgical approach using lymphovenous anastomosis (LVA), vascularized lymph node transfer (VLNT), possibly combined with liposuction in one or two stages
Standard conservative management with complex decongestive therapy (CDT) delivered by physiotherapists
Role in trial
Investigational surgical treatment arm
Active comparator representing standard care
Primary use
To improve quality of life for chronic breast cancer–related lymphedema unresponsive to conservative therapy
To manage symptoms of chronic lymphedema through conservative therapy
How it is performed
Performed by specialized microsurgeons in one or two stages; choice of LVA, VLNT, alone or in combination, possibly with liposuction
Delivered at dedicated lymphedema therapy clinics by physiotherapists following recommended procedures
Evidence status
Emerging observational and systematic review data suggest moderate volume reduction and improved quality of life (approx 30‑40 %) with LVA and VLNT
Widely accepted symptom management approach but often insufficient to halt disease progression
Important risks
Surgery carries procedural risks; specific complication rates vary and require further study
Generally low‑risk conservative therapy
Important limitations
Evidence primarily from observational single‑center studies; lack of high‑quality RCT data prior to this trial
Provides symptomatic relief but often does not prevent progression or restore lymphatic function
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Written informed consent.
Patients 18 years of age or older.
Previous diagnosis of breast cancer.
Clinical diagnosis of chronic breast cancer-related lymphedema lasting more than 3 months, stage 1 or higher.
At least 3 months of conservative complex physical decongestion therapy.
Ability to complete quality of life questionnaires.
Willingness to undergo surgery.
You will not qualify if you...
No indication for lymphatic surgery based on surgeon's clinical judgment.
Primary congenital lymphedema or lymphedema not related to breast cancer.
Previous surgical treatment for breast cancer-related lymphedema on the affected side.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Treatment
Duration - Up to 15 months
Participants receive either lymphatic surgery using advanced microsurgical techniques or conservative physical therapy according to their assigned group.
Visits at baseline and regular intervals up to 15 months
Long-term Follow-up
Duration - Up to 10 years
Participants are followed for up to 10 years with assessments of quality of life, arm volume, pain, complications, and other health measures.
Periodic visits for assessments
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Evaluating the Safety and Effectiveness of the Dayspring Wearable Compression System for Breast Cancer Related Lymphedema After Lymphatic Surgery
Evaluating Gentle Touch Therapy for Lymphedema After Breast Cancer Surgery in Women Aged 30 to 75
Study of LYMPHA Procedure to Prevent Lymphedema in Women Undergoing Axillary Lymphadenectomy for Breast Cancer
Surgical Lymphovenous Anastomosis to Prevent Breast Cancer-Related Lymphedema in Women Undergoing Axilla Dissection
LYMPH Trial Comparing Microsurgical and Conservative Treatments for Chronic Breast Cancer-Related Lymphedema An International Randomized Multicenter Study
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The LYMPH trial: comparing microsurgical with conservative treatment for chronic breast cancer-associated lymphoedema - study protocol of a pragmatic randomised international multicentre superiority trial.
Elisabeth A Kappos, Yvonne Haas, Alexandra Schulz...